|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Statin-associated myopathy显示文摘 | Thompson PD Clarkson P Karas RH | 2003 | JAMA2003，289，： | 1 |
| 2 | Estrogen inhibits the vascolar injury response in estrogen receptor alpha-deficient mice显示文摘 | Iarati MD Karas RH Aronovitz M | 1997 | Nat Med1997，3，5： | 1 |
| 3 | Effects of estrogen on the vascular injury response in estrogen receptor alpha,beta(double) knoekout mice显示文摘 | Karas RH SchultenH Pare G | 2001 | CircRes2001，89，6： | 1 |
| 4 | The protective effects of oestrogen on the cardiovascular system显示文摘 | Mendelsohn ME Karas RH | 1999 | N Engl J Med1999，340，： | 1 |
| 5 | Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose- lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose) 显示文摘 | Alsheikh-Ali AA Abourjaily HM Karas RH | 2002 | Am J Cardiol2002，89，11： | 1 |
| 6 | The protective effects of estrogen on the cardiovascular system显示文摘 | Karas RH | 1999 | N Engl J Med1999，340，： | 1 |
| 7 | Statin- associated myopathy显示文摘 | Thompson PD Clarkson P Karas RH | 2003 | JAMA2003，289，： | 1 |
| 8 | Statin use enhances coronary collaterals显示文摘 | Karas RH | 2003 | Am Heart J2003，146，： | 1 |
| 9 | Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk显示文摘 | Jafri H Alsheikh-Ali AA Karas RH | 2010 | Ann Intern Med2010，153，12： | 1 |
| 10 | Estrogen inhibits the vascular injury response in estrogen receptor -deficient mice显示文摘 | Infrati MD Karas RH Aronovitz M | 1997 | Nature Med1997，3，5： | 1 |
| 11 | The protective effects of estrogen on the cardiovascular system显示文摘 | Mendelsohn ME Karas RH | 1999 | N Engl J Med1999，340，23： | 1 |
| 12 | Statin-associated myopathy 显示文摘 | THOMPSON PD LARKSON P KARAS RH | 2003 | JAMA2003，289，13： | 1 |
| 13 | Safety of lovastatin/extended reaJease niacin compared with |ovastatin alone,atorvastatin alone,pravastatin a- lone and simvastatin alone显示文摘 | Alsheikh-Ali AA Karas RH | 2006 | Am J Cardiol2006，99，3： | 1 |
| 14 | Human vascular smooth muscle cells contain functional estrogen receptor显示文摘 | Patterson BL Mendelsohn ME | 1994 | Circulation1994，89，5： | 1 |
| 15 | Effects of statins on vascular structure and function : a systematic review 显示文摘 | Balk EM Karas RH Jordan HS | 2004 | Am J Med2004，117，10： | 1 |
| 16 | Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from FDA Administration adverse event reporting system) 显示文摘 | AESHEIKH-ALI AA KARAS RH | 2007 | Am J Cardiol2007，99，3： | 1 |
| 17 | Estrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of platelet-derived growth factor receptor-beta and ERK-1/2显示文摘 | Finlay GA York B Karas RH | 2004 | J Biol Chem2004，279，23： | 1 |
| 18 | Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patientswith dyslip idemia: the OCEANS study 显示文摘 | KARAS RH KASHYAP ML KNOPP RH | 2008 | Am J Cardiovasc Drugs2008，8，2： | 1 |
| 19 | Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double)knockout mice 显示文摘 | Karas RH Schulten H Pare G | 2001 | Cire Res2001，89，： | 1 |
| 20 | The protective effects of estrogen onthe cardiovascular system 显示文摘 | Mendelsohn ME Karas RH | 1999 | N Engl J Med1999，340，23： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员